SUGEMALIMAB
UNII 90IQR2I6TR

Substance Identification & Data

This profile provides standardized clinical and technical data for Sugemalimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 90IQR2I6TR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2256084-03-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

90IQR2I6TR

CAS Registry Number

2256084-03-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SUGEMALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C154550

National Cancer Institute reference terminology for clinical and research data.

INN ID

11330

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sugemalimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SUGEMALIMAB

Common Names & Synonyms

ANTI-PD-L1 MONOCLONAL ANTIBODY CS1001

ANTI-PD-L1 MONOCLONAL ANTIBODY WBP 3155

SUGEMALIMAB [INN]

SUGEMALIMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G4 (228-PROLINE) (ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1)) (HUMAN MONOCLONAL CS1001 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CS1001 .LAMBDA.-CHAIN, DIMER

SYS